Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: FDA FY 1998 budget

This article was originally published in The Gray Sheet

Executive Summary

FDA FY 1998 budget: House Appropriations/Agriculture Subcommittee scheduled to hold mark-up June 25 on proposal allocating $13.65 bil. among FDA, Department of Agriculture, Farm Credit Administration and Commodities Future Trading Commission. The $13.65 bil. allocation for FY 1998 received from the full committee is comparable to last year's $12.9 bil. when cuts in welfare programs are accounted for. The subcommittee says FDA is a high priority, but acknowledges it will be difficult to make up for the $68 mil. cut in federal outlays for the agency proposed in the Administration's budget ("The Gray Sheet" Feb. 10, p. 3). The Senate Appropriations Committee allocates $13.748 bil. for agriculture and related agencies (including FDA)...

You may also be interested in...



Quotable: Words Of Wisdom From Our Recent APAC Coverage

Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.

Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification

Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.

Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round

Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT008268

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel